Fred Hutch Cancer Center’s Rare Cancer Patient and Caregivers’ Symposium held March 14 and sponsored by TRACER, Fred Hutch's ...

Though TB remains the world's top infectious disease killer, there's cause for hope, Fred Hutch Cancer Center experts say.

Join us as we explore the latest advancements in immunotherapy at Fred Hutch, including CAR T-cell therapy, novel agents, ...

We asked Fred Hutch experts for their best advice on how people in Washington state can still get cancer screenings even ...

SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...

In this episode of From Bench to Bedside and Beyond, Dr. Yaw Nyame and patient Dave Lucas discuss the robotic surgical ...

SEATTLE — Feb. 26, 2026 — Fred Hutch Cancer Center announced 12 recipients of the Harold M. Weintraub Graduate Student Award, which honors the exceptional achievements of graduate students in the ...

Researchers from two labs in the Human Biology division at Fred Hutch Cancer Center recently published two studies aimed at ...

Fred Hutch Cancer Center medical oncologist Dr. Lisa Tachiki has been named a 2025 Cancer Research Fellow by the Kuni Foundation, an honor that includes an unrestricted, two-year $300,000 award.

Over the last decade, the cellular cancer immunotherapy known as CAR T-cell therapy has roared to the rescue of many blood cancer patients. The engineered immune cells revolutionized treatment of ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...

Some patients become advocates because everything went right: the diagnosis was made early, the surgery went well, the cancer-driving mutation was found and communicated to other family members, ...